Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2021

Dec 15, 2021

35119_dirs_2021-12-15_159a3f41-3ff9-4439-9d43-79eab05ca03c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2021-12-14

Reporting Person: Guarino Jonathan L. (Senior Vice President and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-14 COMMON STOCK P 10000 $0.7119 Acquired 10000 Direct